Related Experiment Video
Updated: Jul 7, 2026
06:15
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
A multidisciplinary approach to therapy for unresectable malignant thymoma
D M Shin1, G L Walsh, R Komaki
1The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
Annals of Internal Medicine
|July 21, 1998
Summary
This study shows aggressive multimodal therapy, including chemotherapy, surgery, and radiation, significantly improves survival and resectability for advanced thymoma. The treatment offers a potential cure for unresectable malignant thymoma.
Area of Science:
- Oncology
- Thoracic Surgery
- Medical Oncology
Background:
- Malignant thymoma, particularly unresectable, locally advanced forms, has historically presented poor therapeutic outcomes.
- The challenge lies in improving treatment efficacy for this rare thoracic malignancy.
Purpose of the Study:
- To evaluate a multimodal therapeutic approach for unresectable malignant thymoma.
- The goal was to enhance tumor resectability and improve patient survival rates.
Main Methods:
- A prospective cohort study was conducted at a tertiary care cancer center.
- The multimodal regimen included induction chemotherapy (cyclophosphamide, doxorubicin, cisplatin, prednisone), surgical resection, postoperative radiation therapy, and consolidation chemotherapy.
- Tumor necrosis and Ki-67 expression were assessed post-surgery.
Main Results:
- Of 12 evaluable patients, 11 underwent surgical resection.
- Complete or partial response to induction chemotherapy was observed in 92% of patients.
- At 7 years, all patients were alive, with a 73% disease-free survival rate.
- A strong correlation was found between tumor necrosis and Ki-67 expression (r=-0.88).
Conclusions:
- Aggressive multimodal treatment demonstrates high effectiveness for locally advanced, unresectable malignant thymoma.
- This therapeutic strategy holds the potential for curative outcomes in patients with this condition.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.